Asia Pacific Synthetic Biology Market is expected to grow at a CAGR of 27% during the forecast period and market is expected to reach US$ 6.21 Bn. by 2027. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. To know about the Research Methodology:-Request Free Sample Report
Global Synthetic Biology Market Dynamics:Synthetic biology is formed from the convergence between engineering and biology that allows development of genetically modified micro-organisms and plants. It enables to achieve an idea related to a product in a faster and cheaper way having greater precision as well. Synthetic biology as a concept allows the building of new biological systems that are naturally unavailable for uses across different end-use industries. The complex synthesis process can be applied across various levels of biological structures from cells to organisms. Fabrication of biological components with the help of DNA allows researchers to gain knowledge regarding genomics thereby leading them to manufacture cataloged DNA sequences. This can be later assembled into newer genomes by researchers for new development which can even be commercialized. Improvements in both speed, as well as cost for synthesizing modified bacterial chromosomes, are enabling scientists to produce advanced bio-products, biofuels and chemicals. Asia Pacific Synthetic Biology Market has been segmented on the basis of product, technology, application, and geography. Based on products the market has been segmented into enabling products and core products. Enabling products held a major market share with more researchers focused on developing new products using existent data and genomics. Demand has been pretty high for genetically modified products and organisms that may be able to cure present anomalies in healthcare and other industries. Government funding has further helped research organizations to come with more commercially viable projects that may help in the long-term sustainability of the human population. On the basis of technology, the market for synthetic biology has been segmented into genome engineering, DNA sequencing, bioinformatics, biological components and integrated systems among others. Genome engineering formed a dominant segment with factors such as increased emphasis on the development of commercially viable biological systems through modification in labs acting as a major driver for this segment. Considering the application segment healthcare and chemicals both have formed two major segments of this market. Agriculture has also seen high growth rate during the last few years in terms of synthetic biology applications. It is also seen that growing research for the development of commercially viable products has further helped in the commercial application of synthetic biology across different end-use industries. China, India, and Japan have formed a few major countries in the Asia Pacific that has contributed to the overall growth. The Asia Pacific has seen huge investments in the last few years with large-scale foreign investment focused on developing genetically modifies crops, chemicals, and organisms that may also have the power to treat certain terminal diseases. All these factors along with growth in government funding for boosting research sector especially in the biological sector has helped in the overall growth of the synthetic biology market in the Asia Pacific.
Synthetic Biology Market, Research Methodology:The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country specific data was accumulated to come up with regional numbers and then arrive at the market value for Asia Pacific Synthetic Biology market.
Synthetic Biology Market, Key Highlights:• Synthetic Biology Market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Synthetic Biology Market • Synthetic Biology Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Synthetic Biology Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Synthetic Biology Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Synthetic Biology Market are also profiled. The report has considered the base year of 2019 and past four years trend. 2020 figures are at actuals, however due to different dynamics of year 2020, market forecast is not only dependent upon 2020, but on the basis of 2016-2020.
Asia Pacific Synthetic Biology market key player• Thermo Fisher Scientific Inc. • Integrated DNA Technologies, Inc. • Synthetic Genomics Inc. • Genscript Corporation • Amyris • Intrexon • Dupont • Agilent Technologies • Novozymes • Origene Technologies, Inc. • Royal DSM N. V. • New England Biolabs, Inc.
Synthetic Biology Market, Key Target Audience:• Research and consulting firms • Healthcare industries • Synthetic Biology Market Investors • Chemical & Biofuel industries • Pharmaceutical & drug manufacturers • Hospitals and Clinics • Contract research organizations (CROs) and Contract manufacturing organizations (CMOs) • Biotech, Food & agriculture , Pharmaceutical & drug manufacturers • Synthetic Biology Marketing Players
Scope of the Synthetic Biology Market Report: Inquire before buyingThe research report segments Asia Pacific Synthetic Biology market based on product, technology, application and geography.
Synthetic Biology Market, By Product:• Enabling • Core
Synthetic Biology Market, By Technology:• Genome Engineering • DND Sequencing • Bioinformatics • Biological components and integrated systems • Others
Synthetic Biology Market, By Application:• Chemicals • Healthcare • Agriculture • Others
Synthetic Biology Market, By Geography:• Asia Pacific • China • Japan • India • South Korea • Australia • Others
Synthetic Biology Market, Geographic Analysis:• Breakdown of China Synthetic Biology market • Breakdown of Japan Synthetic Biology market • Breakdown of India Synthetic Biology market • Breakdown of South Korea Synthetic Biology market • Breakdown of Australia Synthetic Biology market • Breakdown of Others Synthetic Biology market
Available Customizations:Maximize Market Research offers customizations of reports according to the specific requirement of our clients
1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET VARIABLES & SCOPE 3.1. Market Segmentation & Scope 3.2. Market Driver Analysis 3.3. Market Restraint Analysis 3.4. Penetration &Growth Prospect Mapping 3.5. Market SWOT Analysis, By Factor (political & legal, economic and technological) 3.6. Porter’s Five ForcesIndustry Analysis 3.7. Market Value Chain Analysis 4. PRODUCTESTIMATES & TREND ANALYSIS (2019 – 2026) 4.1. Synthetic Biology Market: ProductAnalysis 4.2. Enabling 4.2.1. Enabling market, 2019 – 2026 (USD billion) 4.3. Core 4.3.1. Coremarket, 2019 – 2026 (USD billion) 5. TECHNOLOGYESTIMATES & TREND ANALYSIS (2019 – 2026) 5.1. Synthetic Biology Market: TechnologyAnalysis 5.2. Genome Engineering 5.2.1. Genome Engineering market, 2019 – 2026 (USD billion) 5.3. DND Sequencing 5.3.1. DND Sequencing market, 2019 – 2026 (USD billion) 5.4. Bioinformatics 5.4.1. Bioinformatics market, 2019 – 2026 (USD billion) 5.5. Biological components and integrated systems 5.5.1. Biological components and integrated systemsmarket, 2019 – 2026 (USD billion) 5.6. Others 5.6.1. Othersmarket, 2019 – 2026 (USD billion) 6. APPLICATION ESTIMATES & TREND ANALYSIS (2019 – 2026) 6.1. Synthetic Biology Market: Application Analysis 6.2. Chemical 6.2.1. Chemicalmarket, 2019 – 2026 (USD billion) 6.3. Healthcare 6.3.1. Healthcare market, 2019 – 2026 (USD billion) 6.4. Agriculture 6.4.1. Agriculture market, 2019 – 2026 (USD billion) 6.5. Others 6.5.1. Othersmarket, 2019 – 2026 (USD billion) 7. REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT, TECHNOLOGY AND APPLICATION (2019 – 2026) 7.1. Synthetic Biology market share by country, 2019 & 2025 7.2. China 7.2.1. China Synthetic Biology market, 2019 – 2026 (USD billion) 7.3. Japan 7.3.1. Japan Synthetic Biology market, 2019 – 2026 (USD billion) 7.4. India 7.4.1. India Synthetic Biology market, 2019 – 2026 (USD billion) 7.5. South Korea 7.5.1. South Korea Synthetic Biology market, 2019 – 2026 (USD billion) 7.6. Australia 7.6.1. Australia Synthetic Biology market, 2019 – 2026 (USD billion) 7.7. Others 7.7.1. Others Synthetic Biology market, 2019 – 2026 (USD billion) 8. MARKET COMPETITION ANALYSIS 8.1. Strategy Framework 8.2. Company Profiles 8.2.1. Thermo Fisher Scientific Inc. 184.108.40.206. Company Overview 220.127.116.11. Financial Performance 18.104.22.168. Product Benchmarking 22.214.171.124. Strategic Initiatives 8.2.2. Integrated DNA Technologies, Inc. 126.96.36.199. Company Overview 188.8.131.52. Financial Performance 184.108.40.206. Product Benchmarking 220.127.116.11. Strategic Initiatives 8.2.3. Synthetic Genomics Inc. 18.104.22.168. Company Overview 22.214.171.124. Financial Performance 126.96.36.199. Product Benchmarking 188.8.131.52. Strategic Initiatives 8.2.4. Genscript Corporation 184.108.40.206. Company Overview 220.127.116.11. Financial Performance 18.104.22.168. Product Benchmarking 22.214.171.124. Strategic Initiatives 8.2.5. Amyris 126.96.36.199. Company Overview 188.8.131.52. Financial Performance 184.108.40.206. Product Benchmarking 220.127.116.11. Strategic Initiatives 8.2.6. Intrexon 18.104.22.168. Company Overview 22.214.171.124. Financial Performance 126.96.36.199. Product Benchmarking 188.8.131.52. Strategic Initiatives 8.2.7. Dupont 184.108.40.206. Company Overview 220.127.116.11. Financial Performance 18.104.22.168. Product Benchmarking 22.214.171.124. Strategic Initiatives 8.2.8. Agilent Technologies 126.96.36.199. Company Overview 188.8.131.52. Financial Performance 184.108.40.206. Product Benchmarking 220.127.116.11. Strategic Initiatives 8.2.9. Novozymes 18.104.22.168. Company Overview 22.214.171.124. Financial Performance 126.96.36.199. Product Benchmarking 188.8.131.52. Strategic Initiatives 8.2.10. Origene Technologies, Inc. 184.108.40.206. Company Overview 220.127.116.11. Financial Performance 18.104.22.168. Product Benchmarking 22.214.171.124. Strategic Initiatives 8.2.11. Royal DSM N. V. 126.96.36.199. Company Overview 188.8.131.52. Financial Performance 184.108.40.206. Product Benchmarking 220.127.116.11. Strategic Initiatives 8.2.12. New England Biolabs, Inc. 18.104.22.168. Company Overview 22.214.171.124. Financial Performance 126.96.36.199. Product Benchmarking 188.8.131.52. Strategic Initiatives